Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Immune checkpoint inhibitor (ICI) therapy has revolutionised the treatment of various cancer types. ICIs reinstate T-cell function to elicit an anti-cancer immune response. The resulting immune response can however have off-target effects which manifest as autoimmune type serious immune-related adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Ik Shin, Khan, Aman, Olsson-Brown, Anna, Papa, Sophie, Middleton, Gary, Palles, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789157/
https://www.ncbi.nlm.nih.gov/pubmed/36564402
http://dx.doi.org/10.1038/s41525-022-00345-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789157/
https://www.ncbi.nlm.nih.gov/pubmed/36564402
http://dx.doi.org/10.1038/s41525-022-00345-6

Ejemplares similares